The ability of the neonatal immune response to handle SARS-CoV-2 infection
Por:
Götzinger F, Santiago-Garcia B, Fumadó V, Brinkmann F, Tebruegge M and ptbnet COVID-19 Study Group
Publicada:
1 mar 2021
Ahead of Print:
1 feb 2021
Resumen:
Filiaciones:
Götzinger F:
Department of Paediatric and Adolescent Medicine, National Reference Centre for Childhood Tuberculosis, Klinik Ottakring, Vienna, Austria
Santiago-Garcia B:
Department of Paediatric Infectious Diseases, University Hospital Gregorio Marañón and Gregorio Marañón Research Institute, Madrid, Spain
Fumadó V:
CIBER of Epidemiology and Public Health, CIBERESP, Madrid, Spain
Department of Paediatrics, Universitat de Barcelona, Barcelona, Spain
Infectious and Imported Diseases, Paediatric Unit, National Referral Unit for Tropical Diseases, Hospital Sant Joan de Déu, Barcelona, Spain
Brinkmann F:
Department of Paediatric Pulmonology, Ruhr University Bochum, Bochum, Germany
Tebruegge M:
Department of Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK
Department of Paediatrics, Royal Children's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
Green Submitted, Bronze
|